US › Healthcare

Mediwound Ltd (MDWD)

US · Healthcare · Biotechnology

$14.30+0.56%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$1.5M
Revenue YoY
-62.7%
Net profit
$-3.0M
Profit YoY
-306.6%
EPS
$-0.23
EPS estimate
$-0.66
Net margin
-200.1%

EPS came in at -0.23 against a street estimate of -0.66 — a beat of 65.2%.

Key statistics

Market cap
$181.5M
Forward P/E
35.0
P/B
4.38
Book value
$3.22
EPS (TTM)
$-2.26
52-week high
$20.30
52-week low
$13.54
50-day MA
$14.56
200-day MA
$16.87
Beta
0.14

Analyst view

Analysts rate Mediwound Ltd a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $30.17.

Shareholding

Insiders
15.88%
Institutions
55.65%

Largest institutional holders

FundStake
Investors Finance Co PLC6.79%
Yelin Lapidot Holdings Management Ltd5.94%
Rosalind Advisors, Inc.5.83%
T. Rowe Price Associates, Inc.5.52%
BlackRock Inc3.47%
Meitav Dash Investments Ltd2.89%
Sphera Funds Management Ltd.2.13%
Silverberg Bernstein Capital Management LLC1.78%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Mediwound Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.